Israeli Scientists Claim to Create Miracle Drug That Completely Cures Cancer

A group of Israeli scientists say a cure for cancer is within their reach, even optimistically predicting that it will be found within a year. The Post reports the drug is based on SoAP technology, which involves the introduction of DNA coding for a protein.

According to its creators, MuTaTo functions as a "cancer antibiotic", using a combination of cancer-targeting peptides (amino acid chains) and also containing a toxin that specifically kills cancer cells.

Dan Aridor, a lead scientist from Accelerated Evolution Biotechnologies Ltd. (AEBi), said his team would have a cure for cancer, according to The Jerusalem Post.

Morad said the treatment could reduce side effects, which often arise because cancer treatments either connect with the wrong or additional targets, or the right targets on healthy cells.

"If it does not completely annihilate the cancer, the remaining cells can start to get mutations again, and then the cancer comes back, but this time it is drug resistant", said Morad. "MuTaTo's multiple-target attack ensures that they will be destroyed as well".

More news: ’I want to be the greatest’: Novak Djokovic targets Roger Federer’s record
More news: Tuchel Urges PSG to Buy Players in January Transfer Window
More news: Mauricio Pochettino’s cup comments will anger Tottenham fans

Because the development of peptides is easier and cheaper, MuTaTo is expected to become an effective alternative for a greater part of the population affected by a variety of cancers. "However, as experience has taught us so many times, the gap from a successful mouse experiment to effective, beneficial application of exciting laboratory concepts to helping cancer patients at the bedside is in fact a long and treacherous journey, filled with unforeseen and unanticipated obstacles".

"This should make the whole molecule non-immunogenic in most cases and would enable repeated administration of the drug", the specialist added. And he says it will "dramatically decrease side effects because it does not target non-cancerous cells as current cancer drugs do".

"I mean, I'd love there to be a cure for cancer, but I do not believe them in the absence of good human evidence", he said.

Chief executive Dr Ilan Morad told the newspaper the treatment, named MuTaTo, will one day be personalised to each individual patient where specific cocktails of drugs will be administered depending on the type of cancer each patient has.

"It can take six to seven years to bring cancer drugs from "mouse to market" - even when drugmakers receive special permissions", said Funtleyder.

Related Articles